Coronary Syndrome
📧 Sign up to get email alerts when something new happens for Coronary Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: Tailored Antiplatelet Therapy Following PCI [Phase 4]
Phase 4 trial evaluating tailored antiplatelet therapy after PCI for coronary artery disease and acute coronary syndrome; results posted aft…
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI [Phase 4]
A Phase 4 clinical trial is evaluating dual antithrombotic therapy with dabigatran and ticagrelor in patients with acute coronary syndrome a…
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Implementing Precision Medicine Approaches to Guide Anti-platelet Selection [Phase 4]
Phase 4 trial update exploring precision medicine approaches to guide anti-platelet selection in acute coronary syndrome and MI settings.
-
FDA approval · 2021-09-07FDA Approved: EPTIFIBATIDE — Original Application (Hainan Shuangcheng Pharmaceuticals Co., Ltd.)
The FDA approved the original ANDA for Eptifibatide from Hainan Shuangcheng Pharmaceuticals Co., Ltd., authorizing a generic version of the …
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomized Trial. [NA]
Clinical trial integration of natural history study and randomized trial in Acute Coronary Syndrome has completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Reduce Bolus Injection of Bivalirudin [Phase 4]
A Phase 4 clinical trial update evaluating reduction of bolus injection of bivalirudin in acute coronary syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: Pharmacodynamic Evaluation of Antiplatelet Effect of Swallowing Versus Chewing Ticagrelor in Patients With Acute Coronary Syndrome [Phase 4]
Phase 4 trial evaluating pharmacodynamic effects of swallowing versus chewing ticagrelor in acute coronary syndrome patients.
-
CLINICAL_TRIALS trial_result · 2021-07-26Clinical Trial Update: Investigating Fear Of Recurrence as a Modifiable Mechanism of Behavior Change [NA]
Clinical trial update on fear of recurrence as a modifiable mechanism of behavior change, completed with results posted in 2021.
-
FDA approval · 2021-07-09FDA Approved: TICAGRELOR — Original Application (Mylan Pharmaceuticals Inc.)
FDA approves Mylan's generic ticagrelor under ANDA 208597.
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: MBCT Delivered Via Group Videoconferencing for ACS Patients With Elevated Depression Symptoms [NA]
Clinical trial update on mindfulness-based cognitive therapy delivered via group videoconferencing for ACS patients with elevated depression…
-
FDA approval · 2021-05-28FDA Approved: BIVALIRUDIN — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved the original application for a generic Bivalirudin product from Slate Run Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2021-05-21Clinical Trial Update: Adrenaline for the Treatment of No-Reflow in Normotensive Patients [Phase 4]
Phase 4 trial update evaluating adrenaline for treating no-reflow in normotensive patients with acute coronary syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: Effects and Plasma Concentration of Ticagrelor, After Crushed and Non-crushed Intake, After Acute Coronary Syndrome [Phase 4]
Phase 4 clinical trial evaluating the effects and plasma concentration of ticagrelor when crushed vs non-crushed in Acute Coronary Syndrome …
-
CLINICAL_TRIALS trial_result · 2021-04-15Clinical Trial Update: Early Risk Stratification in ED Chest Pain Patients
A completed clinical trial evaluating early risk stratification in emergency department chest pain patients with acute coronary syndrome; re…
-
FDA approval · 2021-04-14FDA Approved: BIVALIRUDIN — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for the generic anticoagulant Bivalirudin from Fresenius Kabi USA, LLC.
-
FDA approval · 2021-04-08FDA Approved: TIROFIBAN HYDROCHLORIDE — Original Application (Gland Pharma Limited)
FDA approves the original ANDA for tirofiban hydrochloride from Gland Pharma Limited, establishing a generic tirofiban product.
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: Suxiao Jiuxin Pills in Microvascular Obstruction in Patients With Acute Coronary Syndrome [Phase 4]
Phase 4 clinical trial update for Suxiao Jiuxin Pills in acute coronary syndrome patients with microvascular obstruction.
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW-ACS) [Phase 4]
Phase 4 trial update evaluating whether a lower dose of aspirin after acute coronary syndrome may be more effective.
-
CLINICAL_TRIALS trial_result · 2021-03-09Clinical Trial Update: Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention [Phase 2]
Phase 2 safety data for PZ-128 in subjects undergoing non-emergent percutaneous coronary intervention have been posted.
-
FDA approval · 2021-02-17FDA Approved: BRILINTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Brilinta (ticagrelor) submitted by AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Myocardial Infarction, COmbined-device, Recovery Enhancement Study [NA]
Clinical trial update for a combined-device recovery enhancement study in acute myocardial infarction with completed status and results post…
-
EMA withdrawal · 2021-01-25EMA Withdrawn: Clopidogrel ratiopharm GmbH (clopidogrel) — Archie Samiel s.r.o.
EMA withdrew clopidogrel from Archie Samiel s.r.o.'s product line, with therapeutic areas including peripheral vascular diseases, acute coro…
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Role of Alprazolam in the Management of Acute Coronary Syndrome [Phase 1, Phase 2]
Phase 1/2 clinical trial exploring alprazolam for acute coronary syndrome management; status is unknown based on available data.
-
FDA approval · 2020-12-29FDA Approved: HEPARIN SODIUM — Original Application (BE Pharmaceuticals Inc.)
FDA approved the original ANDA for Heparin Sodium from BE Pharmaceuticals Inc., providing a generic version of heparin for anticoagulation.
-
FDA approval · 2020-12-29FDA Approved: HEPARIN SODIUM — Original Application (BE Pharmaceuticals Inc.)
The FDA approved BE Pharmaceuticals Inc.'s original application for Heparin Sodium (a generic anticoagulant). It is used to prevent and trea…